Skip to main content
. 2017 Dec 15;9(5):5562–5577. doi: 10.18632/oncotarget.23726

Figure 6. Induction of GM1 expression is stable in 10 ng/ml TNFα-treated HAECs.

Figure 6

(A) At day 0, cells were reseeded with 10 ng/ml TNFα in HAEC medium and incubated for 3 days. At day 3, cells were reseeded without TNFα and with or without AMP-dNM in HAEC medium and further incubated for 4 days. At day 7, cells were harvested and analyzed (B-G). Control cells were grown in HAEC medium. (B) Real-time PCR analysis of IRS2 and eNOS performed using cDNA derived from control, 3-day TNFα-treated HAECs and 3-day TNFα-treated HAECs 4 days after removal of TNFα. Results shown were normalized against values obtained for control HAECs (value = 1). (C) FACS analysis of cell surface GM1 performed in control and TNFα-treated HAECs with or without AMP-dNM treatment for 4 days after removal of TNFα. MFIs relative to control HAECs are shown. (D) Real-time PCR analysis of B4GALNT1 performed using cDNA derived from control and TNFα-treated HAECs 4 days after removal of TNFα. Results shown were normalized against values obtained for control HAECs (value = 1). (E) Western blot analysis of insulin signaling performed for TNFα-treated HAECs with or without AMP-dNM treatment 4 days after removal of TNFα. (F) Histograms show mean densitometric readings ± SD of phosphorylated or non-phosphorylated proteins in insulin-stimulated cells normalized to loading controls (β-ACTIN). All values were obtained from three independent experiments. (G) Immunocytochemical staining performed in TNFα-treated HAECs with or without AMP-dNM treatment 4 days after removal of TNFα. Representative images are shown (GM1, green; IRα, red; DAPI, blue; GM1 and IRα co-localization, yellow). *P < 0.05; **P < 0.01. Control (Ctr): untreated cells.